TRACER PHARMA ApS: Financial statements 2021
CVR: 34090106
Source: annual report 2021, Danish Business Authority
01/05/2020 – 30/04/2021
TRACER PHARMA ApS (CVR 34090106) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 3,967,674 and a net result of DKK 832,254 compared with DKK 455,381 the year before. That is a decrease of 9.1% compared with the year before. Equity in the 2021 report amounted to DKK 1,481,965. The solvency ratio was 45.6%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 3,967,674
- Profit/Loss
- DKK 832,254
- Equity
- DKK 1,481,965
- Total Assets
- DKK 3,249,958
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 4 mio. | 832 t. | 1.5 mio. | 5 |
| 2020 | - | 4.4 mio. | 455 t. | 650 t. | 5 |
| 2019 | - | 3 mio. | -330 t. | 194 t. | - |
| 2018 | - | 3.3 mio. | 417 t. | 525 t. | 4 |
| 2017 | - | 2.5 mio. | 20 t. | 227 t. | 4 |
Official annual report
Find more companies like TRACER PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout TRACER PHARMA ApS
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011. The company has been dissolved on 28 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity in the 2025 report amounted to DKK 867,174.